scientific article; zbMATH DE number 3322699
From MaRDI portal
Publication:5602015
zbMath0203.21505MaRDI QIDQ5602015
Publication date: 1963
Title: zbMATH Open Web Interface contents unavailable due to conflicting licenses.
Related Items
Efficient Robbins–Monro procedure for multivariate binary data ⋮ On a new stopping rule for stochastic approximation ⋮ Sequential design for binary dose-response experiments ⋮ On D-optimal designs for binary data ⋮ Optimal Bayesian estimation of the median effective dose ⋮ Sequential empirical Bayesian design for sensitivity experiments ⋮ Robust and efficient estimation of effective dose ⋮ Estimators and D-optimal experimental designs for mixtures of binary responses ⋮ Performance Measures in Dose‐Finding Experiments ⋮ Bayesian sequential experimental design for binary response data with application to electromyographic experiments ⋮ Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates ⋮ Design issues for generalized linear models: a review ⋮ Unnamed Item ⋮ Three-phase optimal design of sensitivity experiments ⋮ Commentary on: ``Three-phase optimal design for sensitivity experiments ⋮ Cumulative cohort design for dose-finding ⋮ Likelihood‐Based Experimental Design for Estimation of Ed 50 ⋮ Group up-and-down designs for dose-finding ⋮ Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach ⋮ Saddlepoint approach to inference for response probabilities under the logistic response model ⋮ Empirical evaluation of a model of global psychophysical judgments. IV : Forms for the weighting function ⋮ The application of stochastic approximation methods to the bio-assay problem ⋮ A distribution‐free approach to qdantal response assays ⋮ Efficient Construction of Test Inversion Confidence Intervals Using Quantile Regression ⋮ A new sequential approximation method ⋮ An Optimizing Up-and-Down Design ⋮ Strong consistency of maximum quasi-likelihood estimators in generalized linear models with fixed and adaptive designs ⋮ Operating characteristics of the standard phase I clinical trial design. ⋮ Bias induced by adaptive dose-finding designs
